(Q40290840)

19 September 2017

title

CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses (English)

1 reference

Corrigendum: CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses

19 September 2017

corrigendum / erratum

1 reference

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1038/NATURE22807

Timothée Bruel

4

0 references

Christine Lacabaratz

object named as

Christine Lacabaratz

8

0 references

Olivier Schwartz

object named as

Olivier Schwartz

10

0 references

Gaël Petitjean

2

object named as

Gaël Petitjean

1 reference

19 September 2017

Benjamin Descours

1

1 reference

19 September 2017

José-Luis López-Zaragoza

3

1 reference

19 September 2017

Raoul Raffel

5

1 reference

19 September 2017

Christina Psomas

6

1 reference

19 September 2017

Jacques Reynes

7

1 reference

19 September 2017

Yves Levy

9

1 reference

19 September 2017

Jean Daniel Lelievre

11

1 reference

19 September 2017

Monsef Benkirane

12

1 reference

19 September 2017

language of work or name

English

0 references

publication date

15 March 2017

1 reference

19 September 2017

1 reference

19 September 2017

volume

543

1 reference

19 September 2017

issue

7646

1 reference

19 September 2017

page(s)

564-567

1 reference

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNATURE21710

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE21710

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE21710

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE21710

SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE21710

SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE21710

Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE21710

SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE21710

SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE21710

Phosphorylation of SAMHD1 by cyclin A2/CDK1 regulates its restriction activity toward HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE21710

Fcgamma receptors as regulators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE21710

The function of Fcγ receptors in dendritic cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE21710

Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE21710

Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE21710

HIV-1 integration landscape during latent and active infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE21710

Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE21710

Elimination of HIV-1-infected cells by broadly neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE21710

HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE21710

LTR real-time PCR for HIV-1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE21710

Designing and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE21710

Re-emergence of HIV after stopping therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE21710

Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNATURE21710

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NATURE21710

1 reference

Dimensions Publication ID

19 September 2017

1084128600

0 references

1 reference